Get started
Author

Sophie B. Willemse

Observed names: S B Willemse, S. B. Willemse, S. Willemse, S.B. Willemse, Sophie B Willemse, Sophie Willemse, Willemse, S. B., Willemse, S.B.
Observed institutions: Queensland Health, Cairns Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Leipzig University
ORCID: 0000-0003-3165-4069
Observed ORCID: 0000-0003-3165-4069
OpenAlex ID: A5072795186
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
2017 · Meike H van der Ree, J Marleen de Vree, et al. · The Lancet · 271
The present and future disease burden of hepatitis C virus ( HCV ) infections with today's treatment paradigm – volume 2
2015 · A. Hatzakis, V. Chulanov, et al. · Journal of Viral Hepatitis · 125
PDF
Historical epidemiology of hepatitis C virus ( HCV ) in select countries – volume 2
2015 · V. Saraswat, S. Norris, et al. · Journal of Viral Hepatitis · 92
PDF
Strategies to manage hepatitis C virus ( HCV ) infection disease burden – volume 2
2015 · E. Gane, D. Kershenobich, et al. · Journal of Viral Hepatitis · 54
PDF
Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti‐MicroRNA‐122, RG‐101
2017 · Femke Stelma, Meike H. van der Ree, et al. · Hepatology · 53
PDF
Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial
2017 · Annikki de Niet, Louis Jansen, et al. · ˜The œLancet. Gastroenterology & hepatology · 51
Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands
2016 · Daniëla K. van Santen, Anneke S. de Vos, et al. · PLoS ONE · 48
PDF
Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B
2022 · Robin Erken, Vladimir Loukachov, et al. · Hepatology · 30
PDF
Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life
2016 · S. B. Willemse, L. C. Baak, et al. · Journal of Viral Hepatitis · 26
PDF
Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy
2021 · Robin Erken, Hans L. Zaaijer, et al. · Annals of Hepatology · 22
PDF
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis
2019 · Sophie Willemse, Colette Smit, et al. · Journal of Viral Hepatitis · 20
PDF
The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.
2015 · S B Willemse, D Razavi-Shearer, et al. · PubMed · 20
PDF
A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients
2022 · Robin Erken, Vladimir V. Loukachov, et al. · Journal of Clinical and Experimental Hepatology · 19
Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir
2016 · S.B. Willemse, L. Jansen, et al. · Antiviral Research · 18
PDF
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
2017 · Meike H. van der Ree, Femke Stelma, et al. · Antiviral Research · 17
PDF
Dynamics of the Immune Response in Acute Hepatitis B Infection
2017 · Femke Stelma, Sophie B Willemse, et al. · Open Forum Infectious Diseases · 17
PDF
Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients
2016 · S B Willemse, D L Bezuur, et al. · Bone Marrow Transplantation · 13
Identification of Liver and Plasma microRNAs in Chronic Hepatitis B Virus infection
2022 · Vladimir V. Loukachov, Karel A. van Dort, et al. · Frontiers in Cellular and Infection Microbiology · 11
Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study
2021 · Cas J Isfordink, Thijs J W van de Laar, et al. · Open Forum Infectious Diseases · 10
PDF
LO7 : A single subcutaneous dose of 2mg/kg or 4mg/kg of RG-101, a GalNAc-conjugated oligonucleotide with antagonist activity against MIR-122, results in significant viral load reductions in chronic hepatitis C patients
2015 · M. Van Der Ree, M.L. de Vree, et al. · Journal of Hepatology · 10
Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study
2016 · Floor A. C. Berden, Robert J. de Knegt, et al. · PLoS ONE · 8
PDF
Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.
2019 · M van Dijk, P A M Kracht, et al. · PubMed · 6
IP-10 in chronic hepatitis C patients treated with high-dose interferon.
2014 · S B Willemse, H W Reesink, et al. · PubMed · 6
The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case Report
2018 · Elise J. Smolders, Sophie B. Willemse, et al. · Annals of Hepatology · 5
PDF
Liver stiffness improvement in hepatitis C patients after successful treatment.
2020 · S M Brakenhoff, M L Verburgh, et al. · PubMed · 2
Works count: 39
Citation count: 955
H-index: 16
I10-index: 20
Year
Topic
Type